Skip Navigation


ToxSci Advance Access originally published online on August 5, 2009
Toxicological Sciences 2009 112(1):4-16; doi:10.1093/toxsci/kfp179
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
112/1/4    most recent
kfp179v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Roberts, R. A.
Right arrow Articles by Slikker, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, R. A.
Right arrow Articles by Slikker, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Society of Toxicology. For permissions, please email: journals.permissions@oxfordjournals.org.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Nitrative and Oxidative Stress in Toxicology and Disease

Ruth A. Roberts*,1, Debra L. Laskin{dagger}, Charles V. Smith{ddagger}, Fredika M. Robertson§, Erin M. G. Allen, Jonathan A. Doorn and William Slikker||

* AstraZeneca R&D Safety Assessment, Alderley Park, UK SK9 1DG {dagger} Department of Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey NJ08854 {ddagger} Center for Developmental Therapeutics, Seattle Children's Research Institute, Seattle, Washington 77030 § Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas IA52242 College of Pharmacy, University of Iowa, Iowa City, Iowa || NCTR, USFDA, Jefferson, Arkansas 72079

1 To whom correspondence should be addressed at AstraZeneca R&D Safety Assessment, Alderley Park, UK. E-mail: ruth.roberts{at}astrazeneca.com.

Received June 15, 2009; accepted July 24, 2009


   Abstract

Persistent inflammation and the generation of reactive oxygen and nitrogen species play pivotal roles in tissue injury during disease pathogenesis and as a reaction to toxicant exposures. The associated oxidative and nitrative stress promote diverse pathologic reactions including neurodegenerative disorders, atherosclerosis, chronic inflammation, cancer, and premature labor and stillbirth. These effects occur via sustained inflammation, cellular proliferation and cytotoxicity and via induction of a proangiogenic environment. For example, exposure to the ubiquitous air pollutant ozone leads to generation of reactive oxygen and nitrogen species in lung macrophages that play a key role in subsequent tissue damage. Similarly, studies indicate that genes involved in regulating oxidative stress are altered by anesthetic treatment resulting in brain injury, most notable during development. In addition to a role in tissue injury in the brain, inflammation, and oxidative stress are implicated in Parkinson's disease, a neurodegenerative disease characterized by the loss of dopamine neurons. Recent data suggest a mechanistic link between oxidative stress and elevated levels of 3,4-dihydroxyphenylacetaldehyde, a neurotoxin endogenous to dopamine neurons. These findings have significant implications for development of therapeutics and identification of novel biomarkers for Parkinson's disease pathogenesis. Oxidative and nitrative stress is also thought to play a role in creating the proinflammatory microenvironment associated with the aggressive phenotype of inflammatory breast cancer. An understanding of fundamental concepts of oxidative and nitrative stress can underpin a rational plan of treatment for diseases and toxicities associated with excessive production of reactive oxygen and nitrogen species.

Key Words: cytokine signaling; carcinogenesis; developmental toxicity; prenatal; inflammation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.